{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:41:54Z","timestamp":1785552114651,"version":"3.56.0"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T00:00:00Z","timestamp":1478822400000},"content-version":"vor","delay-in-days":680,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Doxycycline, a commonly prescribed tetracycline, remains on intermittent shortage. We systematically reviewed the literature to assess minocycline as an alternative to doxycycline in select conditions, given doxycycline's continued shortage. We identified 19 studies, 10 of which were published before 2000. Thirteen of the studies were prospective, but only 1 of these studies was randomized. Based on the available data, we found minocycline to be a reasonable substitute for doxycycline in the following scenarios: skin and soft-tissue infections and outpatient treatment of community-acquired pneumonia in young, otherwise healthy patients or in patients with macrolide-resistant Mycoplasma pneumoniae, as well as Lyme disease prophylaxis and select rickettsial disease should doxycycline be unavailable.<\/jats:p>","DOI":"10.1093\/ofid\/ofv178","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T02:33:10Z","timestamp":1448505190000},"source":"Crossref","is-referenced-by-count":38,"title":["Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review"],"prefix":"10.1093","volume":"2","author":[{"given":"Nicholas W.","family":"Carris","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapeutics and Clinical Research, University of South Florida College of Pharmacy"},{"name":"Departments of Family Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Pardo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, North Florida\/South Georgia Veterans Health System, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Montero","sequence":"additional","affiliation":[{"name":"Internal Medicine, University of South Florida, Morsani College of Medicine, Tampa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy M.","family":"Shaeer","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapeutics and Clinical Research, University of South Florida College of Pharmacy"},{"name":"Internal Medicine, University of South Florida, Morsani College of Medicine, Tampa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"key":"2020081009571349100_OFV178C1","article-title":"Nationwide Shortage of Doxycycline: Resources for Providers and Recommendations for Patient Care","author":"Centers for Disease Control and Prevention"},{"key":"2020081009571349100_OFV178C2","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/cid\/civ201","article-title":"Antibacterial drug shortages from 2001 to 2013: implications for clinical practice","volume":"60","author":"Quadri","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020081009571349100_OFV178C3","article-title":"ASHP Drug Shortages Resource Center","author":"American Society of Health-System Pharmacists"},{"key":"2020081009571349100_OFV178C4","article-title":"Subcommittee on Primary Health and Aging. Why are some generic drugs skyrocketing in price?","author":"United States Senate Committee on Health, Education, Labor and Pensions","year":"2015"},{"key":"2020081009571349100_OFV178C5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.diagmicrobio.2012.11.020","article-title":"Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists","volume":"75","author":"Gundlapalli","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020081009571349100_OFV178C6","article-title":"Trends in Retail Prices of Generic Prescription Drugs Widely Used by Older Americans, 2006 to 2013","author":"AARP Public Policy Institute"},{"key":"2020081009571349100_OFV178C7","article-title":"Minocin\u00ae [package insert]","year":"2010"},{"key":"2020081009571349100_OFV178C8","first-page":"843","article-title":"Tetracycline","volume-title":".","author":"Eisen","year":"2010"},{"key":"2020081009571349100_OFV178C9","article-title":"Vibramycin\u00ae [package insert]","year":"2015"},{"key":"2020081009571349100_OFV178C10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","article-title":"Clinical pharmacokinetics of doxycycline and minocycline","volume":"15","author":"Saivin","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"2020081009571349100_OFV178C11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/inf.1973.5.issue-3.07","article-title":"Studies on doxycycline during intravenous and oral treatment with reference to renal function","volume":"5","author":"Alestig","year":"1973","journal-title":"Scand J Infect Dis"},{"key":"2020081009571349100_OFV178C12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/inf.1974.6.issue-3.10","article-title":"Studies on the intestinal excretion of doxycycline","volume":"6","author":"Alestig","year":"1974","journal-title":"Scand J Infect Dis"},{"key":"2020081009571349100_OFV178C13","first-page":"24","article-title":"The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function","volume":"9","author":"Mahon","year":"1976","journal-title":"Scand J Infect Dis Suppl"},{"key":"2020081009571349100_OFV178C14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00000441-196805000-00005","article-title":"Absorption and excretion of five tetracycline analogues in normal young men","volume":"255","author":"Steigbigel","year":"1968","journal-title":"Am J Med Sci"},{"key":"2020081009571349100_OFV178C15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin Ther"},{"key":"2020081009571349100_OFV178C16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijantimicag.2014.12.031","article-title":"Tetracyclines for multidrug-resistant Acinetobacter baumannii infections","volume":"45","author":"Falagas","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"2020081009571349100_OFV178C17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020081009571349100_OFV178C18","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020081009571349100_OFV178C19","first-page":"227","article-title":"Bacteriologic and clinical evaluation of minocycline, a new tetracycline","volume":"13","author":"Cappel","year":"1971","journal-title":"Curr Ther Res Clin Exp"},{"key":"2020081009571349100_OFV178C20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/AAC.6.5.551","article-title":"Evaluation of the efficacy of minocycline therapy for staphylococcal soft-tissue infection","volume":"6","author":"Phair","year":"1974","journal-title":"Antimicrob Agents and Chemother"},{"key":"2020081009571349100_OFV178C21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archderm.1975.01630190064005","article-title":"Minocycline in staphylococcal soft-tissue infections","volume":"111","author":"Raff","year":"1975","journal-title":"Arch Dermatol"},{"key":"2020081009571349100_OFV178C22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/13.suppl_C.17","article-title":"Treatment of severe staphylococcal infections with a rifampicin-minocycline association","volume":"13","author":"Clumeck","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"2020081009571349100_OFV178C23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/429628","article-title":"Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature","volume":"40","author":"Ruhe","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020081009571349100_OFV178C24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.7205\/MILMED.171.6.504","article-title":"Outcomes of community-acquired, methicillin-resistant Staphylococcus aureus, soft tissue infections treated with antibiotics other than vancomycin","volume":"171","author":"Barnes","year":"2006","journal-title":"Mil Med"},{"key":"2020081009571349100_OFV178C25","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1128\/AAC.00262-07","article-title":"Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus","volume":"51","author":"Ruhe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081009571349100_OFV178C26","first-page":"194","article-title":"Clinical evaluation of intravenous minocycline","volume":"15","author":"Rogers","year":"1977","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"2020081009571349100_OFV178C27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1440-1843.2011.02102.x","article-title":"Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients","volume":"17","author":"Kawai","year":"2012","journal-title":"Respirology"},{"key":"2020081009571349100_OFV178C28","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children","volume":"55","author":"Okada","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020081009571349100_OFV178C29","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.00048-13","article-title":"Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081009571349100_OFV178C30","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/AAC.00737-13","article-title":"Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy","volume":"57","author":"Miyashita","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081009571349100_OFV178C31","first-page":"377","article-title":"Antibiotic therapy in early erythema migrans disease and related disorders","volume":"263","author":"Weber","year":"1987","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"key":"2020081009571349100_OFV178C32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/archderm.1995.01690180052010","article-title":"No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment","volume":"131","author":"Muellegger","year":"1995","journal-title":"Arch Dermatol"},{"key":"2020081009571349100_OFV178C33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01780662","article-title":"Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis","volume":"24","author":"Breier","year":"1996","journal-title":"Infection"},{"key":"2020081009571349100_OFV178C34","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/JCM.34.6.1359-1363.1996","article-title":"Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy","volume":"34","author":"Schmidt","year":"1996","journal-title":"J Clin Microbiol"},{"key":"2020081009571349100_OFV178C35","first-page":"951","article-title":"Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three Borrelia species","volume":"111","author":"Stanek","year":"1999","journal-title":"Wien Klin Wochenschr"},{"key":"2020081009571349100_OFV178C36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archderm.142.7.862","article-title":"Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients","volume":"142","author":"Glatz","year":"2006","journal-title":"Arch Dermatol"},{"key":"2020081009571349100_OFV178C37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10156-002-0223-5","article-title":"Clinical study of Japanese spotted fever and its aggravating factors","volume":"9","author":"Kodama","year":"2003","journal-title":"J Infect Chemother"},{"key":"2020081009571349100_OFV178C38","doi-asserted-by":"crossref","first-page":"700","DOI":"10.11150\/kansenshogakuzasshi.88.700","article-title":"[First case report of fatal Japanese spotted fever in Kumamoto Prefecture and the investigation of severe cases in Kamiamakusa City]","volume":"88","author":"Tenjin","year":"2014","journal-title":"Kansenshogaku Zasshi"},{"key":"2020081009571349100_OFV178C39","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10156-013-0575-z","article-title":"Atelectasis caused by macrolide-resistant Mycoplasma pneumoniae pneumonia in an adult patient","volume":"19","author":"Miyashita","year":"2013","journal-title":"J Infect Chemother"},{"key":"2020081009571349100_OFV178C40","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2169\/internalmedicine.51.6214","article-title":"A case of Japanese spotted fever complicated with central nervous system involvement and multiple organ failure","volume":"51","author":"Nakata","year":"2012","journal-title":"Intern Med"},{"key":"2020081009571349100_OFV178C41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10156-011-0301-7","article-title":"A 7-year-old girl with subcutaneous emphysema, pneumomediastinum, pneumothorax, and pneumoretroperitoneum caused by Mycoplasma pneumoniae pneumonia","volume":"18","author":"Inamo","year":"2012","journal-title":"J Infect Chemother"},{"key":"2020081009571349100_OFV178C42","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1365-4632.2010.04584.x","article-title":"Japanese spotted fever with acute hepatic failure: was it associated with Epstein-Barr virus?","volume":"49","author":"Kondo","year":"2010","journal-title":"Int J Dermatol"},{"key":"2020081009571349100_OFV178C43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1346-8138.2010.00891.x","article-title":"Topical treatment with incision and antiseptic may prevent the severity of Japan spotted fever","volume":"37","author":"Kondo","year":"2010","journal-title":"J Dermatol"},{"key":"2020081009571349100_OFV178C44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10156-009-0692-X","article-title":"Prolonged Mycoplasma pneumoniae infection in an elderly patient with community-acquired pneumonia","volume":"15","author":"Takahashi","year":"2009","journal-title":"J Infect Chemother"},{"key":"2020081009571349100_OFV178C45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.11150\/kansenshogakuzasshi1970.82.77","article-title":"Fulminant Japanese spotted fever--the second fatal case in Japan","volume":"82","author":"Wada","year":"2008","journal-title":"Kansenshogaku Zasshi"},{"key":"2020081009571349100_OFV178C46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0929-6646(08)60011-X","article-title":"African tick bite fever","volume":"107","author":"Tsai","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"2020081009571349100_OFV178C47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10156-007-0535-6","article-title":"Rapid optimization of antimicrobial chemotherapy given to pediatric patients with community-acquired pneumonia using PCR techniques with serology and standard culture","volume":"13","author":"Nakayama","year":"2007","journal-title":"J Infect Chemother"},{"key":"2020081009571349100_OFV178C48","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2169\/internalmedicine.45.1831","article-title":"Severe Japanese spotted fever successfully treated with fluoroquinolone","volume":"45","author":"Seki","year":"2006","journal-title":"Intern Med"},{"key":"2020081009571349100_OFV178C49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7883\/yoken.JJID.2005.112","article-title":"The first reported case of spotted fever in Fukui Prefecture, the northern part of central Japan","volume":"58","author":"Noji","year":"2005","journal-title":"Jpn J Infect Dis"},{"key":"2020081009571349100_OFV178C50","first-page":"840","article-title":"A case of severe Chlamydia pneumoniae pneumonia requiring mechanical ventilation and complicated with disseminated intravascular coagulation","volume":"41","author":"Yanagi","year":"2003","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"2020081009571349100_OFV178C51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s101560170021","article-title":"Japanese spotted fever associated with multiorgan failure","volume":"7","author":"Kodama","year":"2001","journal-title":"J Infect Chemother"},{"key":"2020081009571349100_OFV178C52","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/JCM.39.6.2341-2343.2001","article-title":"Fulminant Japanese spotted fever associated with hypercytokinemia","volume":"39","author":"Iwasaki","year":"2001","journal-title":"J Clin Microbiol"},{"key":"2020081009571349100_OFV178C53","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4269\/ajtmh.2009.09-0101","article-title":"African tick bite fever in a Taiwanese traveler returning from South Africa: molecular and serologic studies","volume":"81","author":"Tsai","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"2020081009571349100_OFV178C54","first-page":"549","article-title":"Susceptibility of the Lyme disease spirochete to seven antimicrobial agents","volume":"57","author":"Johnson","year":"1984","journal-title":"Yale J Biol Med"},{"key":"2020081009571349100_OFV178C55","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3412\/jsb.44.717","article-title":"Comparison of in vitro susceptibilities of Rickettsia prowazekii, R. rickettsii, R. sibirica and R. tsutsugamushi to antimicrobial agents","volume":"44","author":"Miyamura","year":"1989","journal-title":"Nihon Saikingaku Zasshi"},{"key":"2020081009571349100_OFV178C56","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1086\/597807","article-title":"The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi","volume":"199","author":"Bernardino","year":"2009","journal-title":"J Infect Dis"},{"key":"2020081009571349100_OFV178C57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s101560050053","article-title":"In-vitro and in-vivo antibiotic susceptibilities of Lyme disease Borrelia isolated in China","volume":"6","author":"Li","year":"2000","journal-title":"J Infect Chemother"},{"key":"2020081009571349100_OFV178C58","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1346-8138.1995.tb03949.x","article-title":"In vitro and in vivo antibiotic susceptibility of Lyme disease Borrelia isolated from the ixodid tick in Japan","volume":"22","author":"Fujita","year":"1995","journal-title":"J Dermatol"},{"key":"2020081009571349100_OFV178C59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ijantimicag.2013.08.006","article-title":"Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections","volume":"42","author":"Cunha","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"2020081009571349100_OFV178C60","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s10096-014-2113-z","article-title":"Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs)","volume":"33","author":"Cunha","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020081009571349100_OFV178C61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/AAC.01244-06","article-title":"Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic","volume":"51","author":"Szumowski","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081009571349100_OFV178C62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020081009571349100_OFV178C63","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/598510","article-title":"Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300","volume":"48","author":"Schwartz","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020081009571349100_OFV178C64","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020081009571349100_OFV178C65","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMra1312885","article-title":"Community-acquired pneumonia","volume":"371","author":"Musher","year":"2014","journal-title":"N Engl J Med"},{"key":"2020081009571349100_OFV178C66","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMcp1214869","article-title":"Clinical practice. Community-acquired pneumonia","volume":"370","author":"Wunderink","year":"2014","journal-title":"N Engl J Med"},{"key":"2020081009571349100_OFV178C67","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3201\/eid2108.150273","article-title":"Macrolide-resistant Mycoplasma pneumoniae, United States","volume":"21","author":"Zheng","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2020081009571349100_OFV178C68","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"2020081009571349100_OFV178C69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1370\/afm.1601","article-title":"Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death","volume":"12","author":"Rao","year":"2014","journal-title":"Ann Fam Med"},{"key":"2020081009571349100_OFV178C70","article-title":"Amoxil\u00ae [package insert]","year":"2006"},{"key":"2020081009571349100_OFV178C71","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199212173272501","article-title":"A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites","volume":"327","author":"Shapiro","year":"1992","journal-title":"N Engl J Med"},{"key":"2020081009571349100_OFV178C72","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM199208203270806","article-title":"Prevention of Lyme disease after tick bites. A cost-effectiveness analysis","volume":"327","author":"Magid","year":"1992","journal-title":"N Engl J Med"},{"key":"2020081009571349100_OFV178C73","first-page":"945","article-title":"The value of early treatment of deer tick bites for the prevention of Lyme disease","volume":"147","author":"Agre","year":"1993","journal-title":"Am J Dis Child"},{"key":"2020081009571349100_OFV178C74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/infdis\/159.1.136","article-title":"A prospective study of tick bites in an endemic area for Lyme disease","volume":"159","author":"Costello","year":"1989","journal-title":"J Infect Dis"},{"key":"2020081009571349100_OFV178C75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM200107123450201","article-title":"Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite","volume":"345","author":"Nadelman","year":"2001","journal-title":"N Engl J Med"},{"key":"2020081009571349100_OFV178C76","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020081009571349100_OFV178C77","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.2014.10186","article-title":"The connection between evidence-based medicine and shared decision making","volume":"312","author":"Hoffmann","year":"2014","journal-title":"JAMA"},{"key":"2020081009571349100_OFV178C78","first-page":"1","article-title":"Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals","volume":"55","author":"Chapman","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"2020081009571349100_OFV178C79","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/infdis\/155.5.1059","article-title":"In vitro antibiotic susceptibility of Rickettsia rickettsii and Rickettsia conorii: plaque assay and microplaque colorimetric assay","volume":"155","author":"Raoult","year":"1987","journal-title":"J Infect Dis"},{"key":"2020081009571349100_OFV178C80","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1128\/AAC.35.12.2457","article-title":"Antimicrobial therapy of rickettsial diseases","volume":"35","author":"Raoult","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081009571349100_OFV178C81","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1086\/324372","article-title":"Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy","volume":"184","author":"Holman","year":"2001","journal-title":"J Infect Dis"},{"key":"2020081009571349100_OFV178C82","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.52.405","article-title":"National surveillance for Rocky Mountain spotted fever, 1981\u20131992: epidemiologic summary and evaluation of risk factors for fatal outcome","volume":"52","author":"Dalton","year":"1995","journal-title":"Am J Trop Med Hyg"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/4\/ofv178\/33603931\/ofv178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/4\/ofv178\/33603931\/ofv178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T18:05:08Z","timestamp":1718215508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofv178\/2460641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofv178","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015]]},"published":{"date-parts":[[2015]]},"article-number":"ofv178"}}